174 related articles for article (PubMed ID: 8281402)
1. Intravesical oxybutynin chloride and clean intermittent catheterisation in patients with neurogenic vesical dysfunction and decreased bladder capacity.
Prasad KV; Vaidyanathan S
Br J Urol; 1993 Nov; 72(5 Pt 2):719-22. PubMed ID: 8281402
[TBL] [Abstract][Full Text] [Related]
2. Long-term outcome of intravesical oxybutynin in children with detrusor-sphincter dyssynergia: with special reference to age-dependent parameters.
Humblet M; Verpoorten C; Christiaens MH; Hirche H; Jansen K; Buyse G; van Gool JD
Neurourol Urodyn; 2015 Apr; 34(4):336-42. PubMed ID: 24436114
[TBL] [Abstract][Full Text] [Related]
3. [The use of intravesical oxybutynin hydrochloride in patients with neurogenic bladder managed by intermittent catheterization].
Yokoyama O; Ishiura Y; Nakamura Y; Ohkawa M
Hinyokika Kiyo; 1995 Jul; 41(7):521-4. PubMed ID: 7668182
[TBL] [Abstract][Full Text] [Related]
4. Intravesical instillation of oxybutynin hydrochloride therapy for patients with a neuropathic bladder.
Mizunaga M; Miyata M; Kaneko S; Yachiku S; Chiba K
Paraplegia; 1994 Jan; 32(1):25-9. PubMed ID: 8015832
[TBL] [Abstract][Full Text] [Related]
5. The use of intravesical oxybutynin chloride in children with neurogenic bladder.
Greenfield SP; Fera M
J Urol; 1991 Aug; 146(2 ( Pt 2)):532-4. PubMed ID: 1861294
[TBL] [Abstract][Full Text] [Related]
6. Intravesical application of a stable oxybutynin solution improves therapeutic compliance and acceptance in children with neurogenic bladder dysfunction.
Buyse G; Verpoorten C; Vereecken R; Casaer P
J Urol; 1998 Sep; 160(3 Pt 2):1084-7; discussion 1092. PubMed ID: 9719281
[TBL] [Abstract][Full Text] [Related]
7. Follow-up of long-time treatment with intravesical oxybutynin for neurogenic bladder in children.
Amark P; Bussman G; Eksborg S
Eur Urol; 1998 Aug; 34(2):148-53. PubMed ID: 9693251
[TBL] [Abstract][Full Text] [Related]
8. Expanded followup of intravesical oxybutynin chloride use in children with neurogenic bladder.
Kaplinsky R; Greenfield S; Wan J; Fera M
J Urol; 1996 Aug; 156(2 Pt 2):753-6. PubMed ID: 8683776
[TBL] [Abstract][Full Text] [Related]
9. Long-term intravesical oxybutynin chloride therapy in children with myelodysplasia.
Painter KA; Vates TS; Bukowski TP; Fleming P; Freedman AL; Smith CA; Gonzalez R; Perlmutter AD
J Urol; 1996 Oct; 156(4):1459-62. PubMed ID: 8808907
[TBL] [Abstract][Full Text] [Related]
10. Early cystometrograms can predict the response to intravesical instillation of oxybutynin chloride in myelomeningocele patients.
Connor JP; Betrus G; Fleming P; Perlmutter AD; Reitelman C
J Urol; 1994 Apr; 151(4):1045-7. PubMed ID: 8126787
[TBL] [Abstract][Full Text] [Related]
11. [Value of intravesically instilled oxybutynin in refractory bladder hyperactivity. Study of 15 cases].
Amarenco G; Adba MA; Kerdraon J
Prog Urol; 1992; 2(4):660-3. PubMed ID: 1302108
[TBL] [Abstract][Full Text] [Related]
12. Treatment of neurogenic bladder dysfunction in infants and children with neurospinal dysraphism with clean intermittent (self)catheterisation and optimized intravesical oxybutynin hydrochloride therapy.
Buyse G; Verpoorten C; Vereecken R; Casaer P
Eur J Pediatr Surg; 1995 Dec; 5 Suppl 1():31-4. PubMed ID: 8770576
[TBL] [Abstract][Full Text] [Related]
13. Intravesical instillation of oxybutynin hydrochloride for detrusor hyper-reflexia.
O'Flynn KJ; Thomas DG
Br J Urol; 1993 Nov; 72(5 Pt 1):566-70. PubMed ID: 10071538
[TBL] [Abstract][Full Text] [Related]
14. The pharmacokinetics of intravesical and oral oxybutynin chloride.
Massad CA; Kogan BA; Trigo-Rocha FE
J Urol; 1992 Aug; 148(2 Pt 2):595-7. PubMed ID: 1640530
[TBL] [Abstract][Full Text] [Related]
15. Intravesical oxybutinin chloride in children with intermittent catheterization: sonographic findings.
Zerin JM; DiPietro MA; Ritchey ML; Bloom DA
Pediatr Radiol; 1994; 24(5):348-50. PubMed ID: 7824373
[TBL] [Abstract][Full Text] [Related]
16. Effect of intermittent urethral catheterization and oxybutynin bladder instillation on urinary continence status and quality of life in a selected group of spinal cord injury patients with neuropathic bladder dysfunction.
Vaidyananthan S; Soni BM; Brown E; Sett P; Krishnan KR; Bingley J; Markey S
Spinal Cord; 1998 Jun; 36(6):409-14. PubMed ID: 9648197
[TBL] [Abstract][Full Text] [Related]
17. Dosage escalation of intravesical oxybutynin in the treatment of neurogenic bladder patients.
Haferkamp A; Staehler G; Gerner HJ; Dörsam J
Spinal Cord; 2000 Apr; 38(4):250-4. PubMed ID: 10822396
[TBL] [Abstract][Full Text] [Related]
18. Side-effects of oral or intravesical oxybutynin chloride in children with spina bifida.
Ferrara P; D'Aleo CM; Tarquini E; Salvatore S; Salvaggio E
BJU Int; 2001 May; 87(7):674-8. PubMed ID: 11350411
[TBL] [Abstract][Full Text] [Related]
19. Topical oxybutynin chloride for relaxation of dysfunctional bladders.
Brendler CB; Radebaugh LC; Mohler JL
J Urol; 1989 Jun; 141(6):1350-2. PubMed ID: 2724432
[TBL] [Abstract][Full Text] [Related]
20. [Intravesical oxybutynin in children with meningomyelocele. Efficient treatment with few side-effects].
Von Zweigbergk M; Nordin B; Jonsson S
Lakartidningen; 1996 Oct; 93(41):3573-6. PubMed ID: 8965514
[No Abstract] [Full Text] [Related]
[Next] [New Search]